GO:0005675 transcription factor TFIIH holo complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005675 describes the transcription factor TFIIH holo complex, a multi-subunit assembly composed of a core TFIIH complex and the TFIIK (CAK) kinase complex.
• The holo complex possesses kinase activity toward the C-terminal domain (CTD) of the largest subunit of RNA polymerase II and is essential for initiation at RNA polymerase II promoters in vitro.
• TFIIH holo complex exists in distinct forms for transcription and DNA repair, including a nucleotide excision repairosome.
• The TFIIK subcomplex contains CDK7, cyclin H, and MAT1, and can exist in three distinct complexes in human cells.
• TFIIH controls developmentally regulated cell cycle progression as a holocomplex.
• Hyperphosphorylation of the RNA polymerase II CTD by TFIIH facilitates dissociation of the polymerase from Mediator.
Description
The transcription factor TFIIH holo complex (GO:0005675) is a large, multi-subunit cellular component that is essential for transcription initiation by RNA polymerase II and for nucleotide excision repair. It is defined as a complex capable of kinase activity directed toward the C-terminal domain (CTD) of the largest subunit of RNA polymerase II, and it is required for initiation at RNA polymerase II promoters in vitro. The holo complex comprises a core TFIIH subcomplex and a separate TFIIK (also known as CAK) kinase subcomplex. This architecture allows TFIIH to function in both transcription and DNA repair, and it exists in different forms depending on its cellular role. Researchers study GO:0005675 because it sits at the intersection of gene regulation, cell cycle control, and genome maintenance. The holo complex is conserved from yeast to humans, and its kinase module can be found in three distinct complexes in human cells. Understanding its composition, assembly, and regulation is critical for interpreting mechanisms of transcription and for developing therapeutic strategies that target transcription-associated kinases.
transcription factor TFIIH holo complex At A Glance
| GO ID | GO:0005675 |
|---|---|
| GO term | transcription factor TFIIH holo complex |
| Ontology | cellular_component |
| Synonym | CAK complex; CDK-activating kinase; cyclin-dependent protein kinase activating kinase holoenzyme complex; holo TFIIH complex |
| Major function | Kinase activity toward the CTD of the largest subunit of RNA polymerase II; essential for initiation at RNA polymerase II promoters in vitro |
| Composition | Core TFIIH complex plus TFIIK complex |
| Related forms | Holo-TFIIH and a nucleotide excision repairosome |
| Subcellular context | Nuclear transcription and DNA repair machinery |
| Conservation | Present in yeast and humans; human CAK exists in three distinct complexes |
What Is GO:0005675?
GO:0005675, the transcription factor TFIIH holo complex, is a cellular component defined as a complex that is capable of kinase activity directed toward the C-terminal domain (CTD) of the largest subunit of RNA polymerase II and is essential for initiation at RNA polymerase II promoters in vitro. It is composed of the core TFIIH complex and the TFIIK complex. Synonyms include CAK complex, CDK-activating kinase, cyclin-dependent protein kinase activating kinase holoenzyme complex, and holo TFIIH complex.
Why Is transcription factor TFIIH holo complex Important in Cell Biology?
The transcription factor TFIIH holo complex is important because it couples transcription initiation with cell cycle control and DNA repair. Its kinase activity toward the RNA polymerase II CTD is required for promoter escape and for the transition from initiation to elongation. In addition, TFIIH controls developmentally regulated cell cycle progression as a holocomplex. Because it is essential for RNA polymerase II transcription, the holo complex is a central node for understanding how gene expression programs are executed and how they are coordinated with proliferation. Its dual role in transcription and nucleotide excision repair makes it relevant to genome stability and to diseases such as cancer and xeroderma pigmentosum.
• Essential for RNA polymerase II promoter initiation in vitro.
• Provides kinase activity toward the CTD of the largest RNA polymerase II subunit.
• Exists as holo-TFIIH and as a nucleotide excision repairosome, linking transcription and DNA repair.
• Controls developmentally regulated cell cycle progression as a holocomplex.
• Contains the TFIIK/CAK subcomplex, which can exist in three distinct complexes in human cells.
• Mediates CTD hyperphosphorylation that facilitates dissociation of RNA polymerase II from Mediator.
• Is targeted by small molecules such as spironolactone, which induces XPB degradation in a TFIIH-integrity-dependent manner.
• Interacts functionally with Mediator through mutual targeting of Mediator and the TFIIH kinase Kin28.
• Participates in transcription start-site scanning through XPB/Ssl2 dsDNA translocase processivity.
• Represents a potential therapeutic target for transcription-addiction and DNA-repair-deficiency cancers.
What Happens During transcription factor TFIIH holo complex?
Transcription initiation and promoter escape
In simple terms: TFIIH helps RNA polymerase II start making RNA and then leave the starting block.
The TFIIH holo complex is essential for initiation at RNA polymerase II promoters in vitro. After initiation, hyperphosphorylation of the C-terminal repeat domain of RNA polymerase II by TFIIH facilitates dissociation of the polymerase from Mediator, allowing promoter escape and productive elongation. The TFIIH kinase module, including Kin28 in yeast, mutually targets Mediator, further coordinating the transition.
CTD kinase activity
In simple terms: TFIIH acts as a kinase that adds phosphate groups to the tail of RNA polymerase II.
The holo complex is defined by its ability to direct kinase activity toward the CTD of the largest subunit of RNA polymerase II. This kinase activity is provided by the TFIIK/CAK subcomplex, which in human cells contains CDK7, cyclin H, and MAT1 and exists in three distinct complexes. The phosphorylation event is a key regulatory step for transcription progression.
DNA repair coupling
In simple terms: TFIIH can switch from a transcription factor into a DNA repair machine.
Different forms of TFIIH exist for transcription and DNA repair, including holo-TFIIH and a nucleotide excision repairosome. This dual functionality allows the complex to participate in nucleotide excision repair while retaining its transcription-related roles. The integrity of TFIIH is required for certain drug-induced degradation pathways, as shown for spironolactone-induced XPB degradation, which requires TFIIH integrity and the ubiquitin-selective segregase VCP/p97.
Transcription start-site scanning
In simple terms: TFIIH helps the transcription machinery find the right start site on DNA.
The XPB/Ssl2 subunit of TFIIH functions as a dsDNA translocase, and its processivity contributes to transcription start-site scanning. This activity is part of the mechanism by which the holo complex ensures correct initiation. The holo complex therefore participates in both the mechanical and catalytic aspects of transcription initiation.
Cell cycle progression control
In simple terms: TFIIH also helps cells decide when to divide.
TFIIH controls developmentally regulated cell cycle progression as a holocomplex. This function links the transcription machinery to cell cycle regulation during development. The presence of the CAK subcomplex, which can act as a CDK-activating kinase, provides a biochemical basis for this cell cycle connection.
Key Genes Involved in GO:0005675 transcription factor TFIIH holo complex
The following genes and proteins are established components or functional partners of the transcription factor TFIIH holo complex (GO:0005675) based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XPB (ERCC3) | Core TFIIH subunit with dsDNA translocase activity; target of spironolactone-induced degradation | Transcription start-site scanning and DNA repair studies |
| XPD (ERCC2) | Core TFIIH subunit involved in DNA repair and transcription | Nucleotide excision repair and transcription coupling |
| CDK7 | Kinase subunit of TFIIK/CAK; phosphorylates RNA polymerase II CTD | Transcription regulation and cell cycle studies |
| Cyclin H | Regulatory partner of CDK7 in the TFIIK/CAK subcomplex | CAK complex assembly and kinase activity |
| MAT1 | Assembly factor and subunit of the TFIIK/CAK subcomplex | Human CAK complex composition |
| Kin28 | Yeast TFIIH kinase that mutually targets Mediator | Mediator-TFIIH interaction studies |
| Ssl2 | Yeast XPB homolog with dsDNA translocase processivity | Transcription start-site scanning mechanisms |
| RNA polymerase II largest subunit | Substrate of TFIIH kinase activity via its CTD | CTD phosphorylation and promoter escape |
| Mediator | Interacts with TFIIH kinase; dissociates upon CTD hyperphosphorylation | Transcription initiation and elongation transition |
| TFIIB | General transcription factor that can form complexes with poly(A) polymerase and cleavage factor 1 subunits | Gene looping and transcription termination studies |
| Poly(A) polymerase | Forms a complex with TFIIB and cleavage factor 1 subunits | Gene looping and 3' end processing |
| Cleavage factor 1 subunits | Part of the TFIIB-poly(A) polymerase complex | mRNA 3' end formation and gene looping |
| VCP/p97 | Ubiquitin-selective segregase required for spironolactone-induced XPB degradation | Protein degradation and TFIIH integrity studies |
| CAK complex components | CDK-activating kinase holoenzyme; exists in three distinct complexes | Kinase complex heterogeneity |
| Core TFIIH subunits | Form the core TFIIH complex within the holoenzyme | Structural and functional dissection of TFIIH |
| TFIIK complex subunits | Form the kinase module of the holo complex | CTD kinase regulation |
How Is transcription factor TFIIH holo complex Regulated?
The transcription factor TFIIH holo complex is regulated at multiple levels. Its kinase activity toward the RNA polymerase II CTD is a key regulatory step that facilitates dissociation of the polymerase from Mediator. The TFIIH kinase Kin28 and Mediator mutually target each other, providing a feedback mechanism during initiation. The integrity of TFIIH is required for certain degradation pathways, as shown by the fact that spironolactone-induced XPB degradation depends on TFIIH integrity and the ubiquitin-selective segregase VCP/p97. In addition, TFIIH controls developmentally regulated cell cycle progression as a holocomplex, indicating that its activity is coupled to developmental signals. The existence of three distinct CAK complexes in human cells suggests that the kinase module can be differentially regulated depending on context.
transcription factor TFIIH holo complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XPB (ERCC3) | DNA repair deficiency; spironolactone-induced degradation | Knockout or point-mutation cell lines for XPB stability and repair assays |
| XPD (ERCC2) | Nucleotide excision repair disorders | Knock-in of patient mutations to study repair and transcription |
| CDK7 | Transcription addiction in cancer | Knockout or point-mutation models to test kinase dependence |
| Cyclin H | CAK complex function in cell cycle | Overexpression and knockout models for CAK assembly |
| MAT1 | CAK complex assembly and cell cycle | Knockout models to assess CAK complex integrity |
Cancer and transcription addiction
The TFIIH holo complex is essential for RNA polymerase II transcription, and its kinase activity is required for promoter escape. Because cancer cells can become dependent on high transcription rates, components of the holo complex such as CDK7 and XPB are considered potential therapeutic targets. Spironolactone induces XPB degradation in a TFIIH-integrity-dependent manner, linking the complex to drug-induced anticancer mechanisms.
DNA repair deficiencies and xeroderma pigmentosum
TFIIH exists in different forms for transcription and DNA repair, including a nucleotide excision repairosome. Defects in TFIIH subunits can impair nucleotide excision repair, which is associated with xeroderma pigmentosum and related disorders. The dual role of TFIIH in transcription and repair explains why mutations in its subunits can cause both developmental and cancer-predisposition phenotypes.
Developmental and cell cycle disorders
TFIIH controls developmentally regulated cell cycle progression as a holocomplex. This function links the complex to developmental processes and to diseases characterized by abnormal cell cycle control. The CAK subcomplex, which can activate cyclin-dependent kinases, provides a direct biochemical connection between TFIIH and the cell cycle machinery.
From transcription factor TFIIH holo complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a TFIIH subunit required for transcription initiation? | Knockout cell model followed by RNA polymerase II CTD phosphorylation assays |
| Does a point mutation in XPB affect DNA repair? | Point-mutation knock-in model with nucleotide excision repair readouts |
| How does CDK7 kinase activity affect promoter escape? | Kinase-dead point-mutation knock-in of CDK7 |
| Where does TFIIH localize during transcription? | Tagged knock-in of a core subunit for imaging |
| Does overexpression of cyclin H alter cell cycle progression? | Overexpression model with cell cycle profiling |
| Can TFIIH integrity be monitored during drug treatment? | Knockout or tagged knock-in models treated with spironolactone |
How to Study the transcription factor TFIIH holo complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro transcription | RNA polymerase II promoter initiation | Testing TFIIH requirement for transcription |
| CTD phosphorylation assay | Kinase activity toward RNA polymerase II CTD | Measuring TFIIH holo complex kinase function |
| Nucleotide excision repair assay | DNA repair activity of the repairosome | Distinguishing transcription and repair forms |
| Co-immunoprecipitation | Protein-protein interactions and complex composition | Defining core TFIIH and TFIIK subunits |
| Live-cell imaging | Subcellular localization and dynamics | Tracking TFIIH subunits after drug treatment |
| Processivity assay | dsDNA translocase activity of XPB/Ssl2 | Studying transcription start-site scanning |
| Cell cycle profiling | Cell cycle progression | Linking TFIIH to developmental cell cycle control |
| Mediator dissociation assay | Interaction between RNA polymerase II and Mediator | Monitoring promoter escape |
Transcriptional and CTD phosphorylation assays
In vitro transcription and CTD phosphorylation assays are used to measure TFIIH holo complex activity, because the complex is defined by its kinase activity toward the RNA polymerase II CTD and its requirement for initiation at RNA polymerase II promoters in vitro. These assays can be combined with Mediator dissociation readouts to monitor promoter escape.
DNA repair and repairosome assays
Because TFIIH exists as holo-TFIIH and as a nucleotide excision repairosome, DNA repair assays are used to distinguish these forms and to measure repair activity. Such assays help determine whether a given TFIIH subunit is required for repair versus transcription.
Protein interaction and complex composition analysis
Co-immunoprecipitation and related interaction methods are used to define the composition of the holo complex, including the core TFIIH and TFIIK subcomplexes. These approaches also help identify distinct CAK complexes in human cells and interactions with Mediator.
Live-cell imaging and degradation studies
Imaging of tagged TFIIH subunits and degradation experiments can reveal dynamic behavior of the complex. For example, spironolactone-induced XPB degradation requires TFIIH integrity and VCP/p97, and can be monitored in cell models. Transcription start-site scanning by XPB/Ssl2 can also be studied using processivity assays.
How CRISPR Can Be Used to Study GO:0005675 transcription factor TFIIH holo complex
Knockout
CRISPR knockout of TFIIH holo complex subunits such as XPB, XPD, CDK7, cyclin H, or MAT1 can be used to test their requirement for transcription initiation and DNA repair. Knockout models are particularly useful for assessing whether a subunit is essential for CTD phosphorylation and promoter escape.
Point Mutation
Point-mutation knock-in can be used to dissect specific activities of TFIIH subunits, such as the kinase activity of CDK7 or the translocase activity of XPB. These models allow separation of catalytic functions from structural roles within the holo complex.
Knock-in
Tagged knock-in of core TFIIH subunits enables imaging and interaction studies without altering endogenous expression levels. Knock-in of disease-associated mutations can also be used to model DNA repair deficiencies linked to TFIIH.
Overexpression
Overexpression of TFIIH subunits or the CAK module can be used to study cell cycle progression and transcription output. Such models help determine whether increased holo complex activity alters developmental or proliferative programs.
How EDITGENE Supports transcription factor TFIIH holo complex Research
Researchers studying transcription factor TFIIH holo complex-related genes often need to determine whether a candidate gene is causally involved in transcription initiation, DNA repair, or cell cycle control. EDITGENE provides CRISPR-based cell model services that enable precise interrogation of GO:0005675 components and their functions.
Contact EDITGENE today to design your custom CRISPR model for transcription factor TFIIH holo complex research.
Frequently Asked Questions About transcription factor TFIIH holo complex
What is the transcription factor TFIIH holo complex?
It is a multi-subunit complex (GO:0005675) capable of kinase activity toward the RNA polymerase II CTD and essential for initiation at RNA polymerase II promoters in vitro, composed of the core TFIIH complex and the TFIIK complex.
What genes are involved in the transcription factor TFIIH holo complex?
Key genes include XPB (ERCC3), XPD (ERCC2), CDK7, cyclin H, MAT1, and in yeast Kin28 and Ssl2, among others.
What is the function of GO:0005675?
It functions in transcription initiation and DNA repair, with kinase activity toward the RNA polymerase II CTD and a role in promoter escape.
How is the TFIIH holo complex different from core TFIIH?
The holo complex includes both the core TFIIH complex and the TFIIK (CAK) kinase complex, whereas core TFIIH lacks the kinase module.
What diseases are linked to TFIIH holo complex dysfunction?
Dysfunction is linked to DNA repair deficiencies such as xeroderma pigmentosum, cancer transcription addiction, and developmental cell cycle disorders.
What is the CAK complex?
CAK (CDK-activating kinase) is a synonym for the TFIIK subcomplex of the TFIIH holo complex, and it exists in three distinct complexes in human cells.
How does TFIIH regulate RNA polymerase II?
It phosphorylates the CTD of the largest RNA polymerase II subunit, facilitating dissociation from Mediator and promoter escape.
Can TFIIH be targeted by drugs?
Yes, spironolactone induces XPB degradation in a TFIIH-integrity-dependent manner requiring VCP/p97.
What methods are used to study the TFIIH holo complex?
In vitro transcription, CTD phosphorylation assays, DNA repair assays, co-immunoprecipitation, imaging, and processivity assays are commonly used.
How can CRISPR help study GO:0005675?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of TFIIH subunits in transcription and repair.
Conclusion
The transcription factor TFIIH holo complex (GO:0005675) is a central cellular component that couples RNA polymerase II transcription initiation with DNA repair and cell cycle control. Its kinase activity toward the CTD of the largest RNA polymerase II subunit is required for promoter escape, and its composition includes both core TFIIH and the TFIIK/CAK kinase module. Studying this complex with CRISPR-based models and biochemical assays continues to reveal how transcription, repair, and proliferation are coordinated in health and disease.
References
- 1. Medler S et al.. 2011. Evidence for a complex of transcription factor IIB with poly(A) polymerase and cleavage factor 1 subunits required for gene looping.. J Biol Chem 286(39):33709-18 PMID: 21835917
- 2. Svejstrup JQ et al.. 1995. Different forms of TFIIH for transcription and DNA repair: holo-TFIIH and a nucleotide excision repairosome.. Cell 80(1):21-8 PMID: 7813015
- 3. Tomko EJ et al.. 2021. The Role of XPB/Ssl2 dsDNA Translocase Processivity in Transcription Start-site Scanning.. J Mol Biol 433(14):166813 PMID: 33453189
- 4. Chauhan AK et al.. 2021. Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97.. Cell Cycle 20(1):81-95 PMID: 33381997
- 5. Matsuno M et al.. 2007. TFIIH controls developmentally-regulated cell cycle progression as a holocomplex.. Genes Cells 12(11):1289-300 PMID: 17986012
- 6. Guidi BW et al.. 2004. Mutual targeting of mediator and the TFIIH kinase Kin28.. J Biol Chem 279(28):29114-20 PMID: 15126497
- 7. Drapkin R et al.. 1996. Human cyclin-dependent kinase-activating kinase exists in three distinct complexes.. Proc Natl Acad Sci U S A 93(13):6488-93 PMID: 8692842
- 8. Søgaard TM et al.. 2007. Hyperphosphorylation of the C-terminal repeat domain of RNA polymerase II facilitates dissociation of its complex with mediator.. J Biol Chem 282(19):14113-20 PMID: 17376774
